ArticleCancer discovery2018

AMG 176, a Selective MCL1 Inhibitor, Is Effective in Hematologic Cancer Models Alone and in Combination with Established Therapies.

Sean Caenepeel et al.PubMed ↗Publisher ↗

No numbers read from the abstract.